G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Data published in The Journal for ImmunoTherapy of CancerOCALA, Fla., Nov. 14, 2023 AIM ImmunoTech Inc. today announced the publication of results from the Phase 1 study at Roswell Park.
Dr. Noor Abuhadra discusses managing adverse events in patients receiving TRODELVY (sacituzumab govitecan), a later-line systemic therapy for metastatic triple-negative breast cancer. Shay Elkins, a patient, shares her experience with significant side effects including diarrhea, low white blood cell counts, and hair loss, while Dr. Abuhadra emphasizes the need for proactive management of these issues to maximize treatment time and maintain quality of life.
Metastatic Prostate Cancer Pipeline Analysis (2023) Covering openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.